Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher to Accelerate Plozasiran Approval for Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. has announced that it has entered into an agreement with an undisclosed third…
LabPMM Launches Global KMT2A MRD Testing Service to Support Precision Monitoring and Clinical Development in Acute Leukemia LabPMM®, a global reference laboratory and subsidiary of Invivoscribe®, has announced the worldwide…
FUJIFILM Biotechnologies Appoints Maja Pedersen as President to Lead Next Phase of Global Growth and Operational Excellence FUJIFILM Biotechnologies has announced a significant leadership transition designed to support the company’s…
Mosaic Therapeutics Strengthens Leadership with Appointment of Dr. Allison Jeynes as Board Chair to Drive Clinical Growth Mosaic Therapeutics, a biotechnology company focused on developing innovative targeted combination therapies for…
Niagen Bioscience Partners with Evotec to Advance NB4168 Development for Rare Genetic Disease Niagen Bioscience, Inc. (NASDAQ: NAGE), a biotechnology company recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide)…
Inocras Raises $31 Million to Accelerate U.S. Expansion of Whole-Genome Sequencing Platform for Precision Oncology Inocras Inc., a bioinformatics-driven precision medicine company specializing in whole-genome sequencing (WGS) and advanced genomic…
Spruce Biosciences Appoints Dr. Jessica Cohen Pfeffer as Vice President of Clinical Development to Advance Rare Neurological Disease Pipeline Spruce Biosciences, Inc., a late-stage biopharmaceutical company dedicated to developing and…
Family Heart Foundation Founder Katherine Wilemon Receives ASPC 2026 Honorary Fellow Award for Advancing Cardiovascular Disease Prevention The Family Heart Foundation, a leading nonprofit organization dedicated to research, education, advocacy,…
Pilatus Biosciences to Present Preclinical Data Highlighting PLT012’s Disease-Modifying Potential in COPD at ERS International Congress 2026 Pilatus Biosciences, a clinical-stage biopharmaceutical company focused on developing innovative metabolic checkpoint immunotherapies…
Seaport Therapeutics Reports Second Quarter 2026 Results, Highlights Positive Clinical Progress and Strengthened Financial Position Following IPO Seaport Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for…
Korsana Biosciences Strengthens Executive Leadership as KRSA-028 Advances Toward Clinical Development for Alzheimer’s Disease Korsana Biosciences, Inc., a biotechnology company focused on discovering and developing innovative therapies for neurodegenerative disorders,…
Zai Lab’s DLL3-Targeting ADC Receives FDA Orphan Drug Designation for Neuroendocrine Carcinomas Zai Lab Limited has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…